Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Palo Alto’s Top Picks for This Year Following Impressive 2015 Returns

#2 Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

– Shares Owned by Palo Alto (as of December 31): 2.19 Million

– Value of Holding (as of December 31): $247.09 Million

The fund cut its holding in Anacor Pharmaceuticals Inc (NASDAQ:ANAC) by 15% during the fourth quarter and shares are down by 43% so far this year amid the company missing both the top- and bottom-line estimates for the last quarter. However, Anacor Pharmaceuticals’ stock surged by more than 250% in 2015 on the back of the possibility of its eczema drug crisaborole receiving regulatory approval. Julian Baker and Felix Baker‘s Baker Bros. Advisors is the largest stockholder of  Anacor Pharmaceuticals Inc (NASDAQ:ANAC) within our database holding about 4.20 million shares valued at $474.31 million.


Follow Anacor Pharmaceuticals Inc. (NASDAQ:ANAC)
Trade (NASDAQ:ANAC) Now!


– Shares Owned by Palo Alto (as of December 31): 2.19 Million

– Value of Holding (as of December 31): $247.09 Million

During the fourth quarter, Palo Alto inched up its exposure to ABIOMED by 2%. Over the last 52 weeks, shares of the provider of temporary percutaneous mechanical circulatory support devices have climbed by more than 31%. Revenue for the company’s third fiscal quarter, ended December 31, came in 38% higher on the year and the guidance for the fiscal 2016 has also been raised to $326 million from a range of $305 million to $315 million. Another shareholder of the company is Drew Cupps’ Cupps Capital Management, which holds about 277,800 shares of ABIOMED, Inc. (NASDAQ:ABMD), according to its latest 13F filing.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.